SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Bob Swift who wrote (2531)4/24/1999 8:40:00 PM
From: Art Vandelay AIA  Read Replies (1) | Respond to of 10280
 
FWI,

Merril Lynch projects Claritan and Claritan D sales of $4.5 Billion in 2003. Now at 7% royalties that would be over $4 of EPS to Sepracor. That is if Nori is not successful I guess. If Nori hurt Claritan sales EPS will only be higher.

HPPOLK